皮膚科OTC薬の世界市場レポート 2025年

皮膚科OTC薬の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.3％で201億6,000万米ドルに成長します。予測期間の成長は、皮膚の健康に対する意識の高まり、世界の高齢化、環境要因、持続可能性とクリーンビューティー、遠隔医療、遠隔コンサルティングなどに起因すると考えられます。予測期間の主な動向には、ニッチな症状別製品、性別にとらわれないスキンケア、多機能製品、微生物に優しいスキンケア、CBD入り製品などが含まれます。

皮膚異常の増加は、今後の皮膚科市販薬（OTC）市場の成長を牽引すると予測されます。皮膚異常とは、皮膚の病変や異常な外観を指します。皮膚科では、これらの異常を治療し、正常な皮膚を回復させるためにOTC薬が利用されます。乾癬をはじめとする皮膚疾患の治療ニーズが高まっていることから、一般用皮膚科治療薬の需要は増加しています。例えば、米国の非営利団体である米国がん協会は、2024年6月、米国で新たに約10万640例のメラノーマが診断され、その内訳は男性が約5万9170例、女性が約4万1470例と推定しています。さらに、男性約5,430人、女性約2,860人を含む約8,290人がメラノーマにより死亡すると予測されています。このように、皮膚異常の発生率の上昇が皮膚科OTC薬市場の成長を促進しています。

eコマースの拡大は、当面の皮膚科OTC薬市場の成長を牽引する重要な役割を担っています。eコマースとは、インターネットを介した商品やサービスのオンライン売買のことで、皮膚科用OTC薬のブランドは、地域の枠を超えて市場範囲を広げることができます。このプラットフォームにより、企業は世界中の消費者に向けて製品をマーケティング・販売することができ、従来の小売チャネルでは特定の製品を手に入れることができなかった消費者にもアクセスを提供することができます。例えば、米国国勢調査局が発表した2023年のデータによると、eコマースの売上高は2022年第3四半期から2023年第3四半期にかけて7.6％増加しました。したがって、eコマースとオンライン薬局の拡大は、皮膚科OTC薬市場を牽引することになると思われます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の皮膚科OTC薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の皮膚科OTC薬市場：成長率分析
• 世界の皮膚科OTC薬市場の実績：規模と成長, 2019-2024
• 世界の皮膚科OTC薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界の皮膚科OTC薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の皮膚科OTC薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 錠剤とカプセル
• オイルジェル
• クリームと軟膏
• その他のタイプ
• 世界の皮膚科OTC薬市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 皮膚炎
• ニキビ
• 乾癬
• 肌の漂白
• 抗真菌
• イボ除去剤
• その他の適応症
• 世界の皮膚科OTC薬市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 話題
• オーラル
• 世界の皮膚科OTC薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オンライン配信
• オフライン配信
• 世界の皮膚科OTC薬市場、タイプ別サブセグメンテーション：錠剤とカプセル剤、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口抗ヒスタミン薬
• 抗炎症薬
• 栄養補助食品
• 世界の皮膚科OTC薬市場、タイプ別サブセグメンテーション：オイルジェル、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハーブオイル
• 薬用ジェル
• 保湿オイル
• 世界の皮膚科OTC薬市場、タイプ別サブセグメンテーション：クリームと軟膏、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイドクリーム
• 抗真菌クリーム
• 保湿剤とエモリエント剤
• 世界の皮膚科OTC薬市場、タイプ別サブセグメンテーション：その他のタイプ、実績と予測, 2019-2024, 2024-2029F, 2034F
• ローション
• スプレー
• フォーム

第7章 地域別・国別分析

• 世界の皮膚科OTC薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の皮膚科OTC薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 皮膚科OTC薬市場：競合情勢
• 皮膚科OTC薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bristol Myers Squibb Co
• GlaxoSmithKline Plc
• Acella Pharmaceuticals LLC
• Eli Lilly and Company
• Amgen Inc.
• Allergan plc
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Astellas Pharma Inc.
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Inc.
• Perrigo Company PLC
• Galderma S.A.
• Dr. Reddy's Laboratories Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 皮膚科OTC薬市場2029：新たな機会を提供する国
• 皮膚科OTC薬市場2029：新たな機会を提供するセグメント
• 皮膚科OTC薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Dermatology over-the-counter (OTC) medications are non-prescription drugs designed for the prevention and treatment of conditions affecting the skin, hair, nails, mouth, and genitalia. These medications are safely and effectively used by the public without the need for consultation with a healthcare practitioner.

The primary forms of dermatology OTC medications include tablets and capsules, oils, gels, creams, ointments, and other formulations. Tablets are solid dosage forms containing drugs, either with or without excipients, while capsules are solid pharmaceutical dosage forms enclosed in a gelatin shell or a suitable material, offering a variety of shapes. An example of an over-the-counter medication is cetirizine, used to address allergy symptoms such as itchy eyes. Dermatology OTC medications are employed to treat various conditions, including dermatitis, acne, psoriasis, skin bleaching, anti-fungal treatments, wart removal, and others. These medications are primarily administered through topical and oral routes and are made available through distribution channels such as online and offline retail outlets.

The dermatology OTC medications market research report is one of a series of new reports from The Business Research Company that provides dermatology OTC medications statistics, including the dermatology OTC medications industry global market size, regional shares, competitors with a dermatology OTC medications market share, detailed dermatology OTC medications market segments, market trends, and opportunities, and any further data you may need to thrive in the dermatology OTC medications industry. This dermatology OTC medications market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The dermatology otc medications market size has grown steadily in recent years. It will grow from $15.77 billion in 2024 to $16.41 billion in 2025 at a compound annual growth rate (CAGR) of 4.0%. The growth in the historic period can be attributed to regulatory changes, demand for convenience, influence of skincare trends, consumer-driven demand, marketing and advertising

The dermatology otc medications market size is expected to see strong growth in the next few years. It will grow to $20.16 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to rising skin health awareness, global aging population, environmental factors, sustainability and clean beauty, telemedicine, and remote consultation. Major trends in the forecast period include niche condition-specific products, gender-neutral skincare, multi-functional products, microbiome-friendly skincare, CBD-infused products.

The rise in skin abnormalities is projected to drive the growth of the dermatology over-the-counter (OTC) medication market in the future. A skin abnormality refers to a skin lesion or an unusual appearance of the skin. In dermatology, OTC drugs are utilized to treat these abnormalities and restore normal skin. The demand for over-the-counter dermatology medications is increasing due to a higher need for treatments for skin conditions, including psoriasis. For example, in June 2024, the American Cancer Society, a US-based non-profit organization, estimated that around 100,640 new cases of melanoma will be diagnosed in the United States in 2024, with approximately 59,170 cases in men and 41,470 in women. Furthermore, around 8,290 deaths from melanoma are anticipated, including about 5,430 men and 2,860 women. Thus, the rising incidence of skin abnormalities is fueling the growth of the dermatology OTC medication market.

The expansion of e-commerce is playing a substantial role in driving the growth of the dermatology OTC medications market in the foreseeable future. E-commerce, which involves the online buying and selling of goods and services over the internet, enables dermatology OTC medication brands to broaden their market reach beyond local boundaries. This platform allows companies to market and sell their products to a global audience, providing access to consumers who may not have availability to specific products through traditional retail channels. For instance, according to the 2023 data released by the United States Census Bureau, e-commerce sales witnessed a 7.6 percent increase from the third quarter of 2022 to the third quarter of 2023. Therefore, the expansion of e-commerce and online pharmacies is poised to drive the dermatology OTC medications market.

Prominent companies in the dermatology over-the-counter (OTC) medications market are actively introducing innovative drugs, such as anti-fungal treatment solutions, to enhance their market profitability. An example of this is Bayer AG, a Germany-based pharmaceutical company, which launched Canesten in May 2022. Canesten, available in various forms such as cream, topical solution, and combination products, serves as an antifungal medication. It is designed to treat fungal skin infections, including vaginal thrush, ringworm, athlete's foot, diaper rash, and sweat rash. The active ingredient in Canesten products is clotrimazole, an antifungal agent that both kills and prevents the growth of fungus. Notably, Canesten is an over-the-counter (OTC) medication considered generally safe for use during pregnancy or while nursing.

Major companies in the dermatology OTC medications market are focusing on developing innovative products, such as generic topical drug formulations, for treating skin diseases. Generic topical drug products are non-branded medications intended for application on the skin or mucous membranes, designed to be bioequivalent to their branded versions in dosage form, strength, and intended use. For example, in April 2022, Sol-Gel Technologies Ltd., an Israel-based dermatology company, launched TWYNEO topical cream. TWYNEO Cream is a fixed-dose combination of tretinoin (0.1%) and benzoyl peroxide (BPO, 3%), aimed at treating inflammatory and non-inflammatory lesions of acne vulgaris in adults and pediatric patients aged nine years and older. A notable feature of TWYNEO Cream is its patented microencapsulation technology, which encloses the active ingredients in silica core shells (microcapsules). This innovative method protects tretinoin from the oxidizing effects of BPO, allowing for the effective combination of both drugs into a single formulation that gradually releases onto the skin.

In February 2022, Taro Pharmaceutical Industries Ltd., a US-based pharmaceutical company, acquired Alchemee for an undisclosed amount. This strategic move positions Taro to strengthen its presence in the over-the-counter dermatology market by incorporating Alchemee's assets and resources, including the Proactiv brand. Additionally, Taro gains access to Alchemee's team expertise in omnichannel marketing. Alchemee, a US-based health, wellness, and fitness company specializing in skin health, direct marketing, and acne, enhances Taro's capabilities in the dermatology OTC medications market.

Major companies operating in the dermatology OTC medications market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Bristol Myers Squibb Co, GlaxoSmithKline Plc, Acella Pharmaceuticals LLC, Eli Lilly and Company, Amgen Inc., Allergan plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Inc., Perrigo Company PLC, Galderma S.A., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Inc., Lupin Limited, LEO Pharma A/S, Almirall S.A.

North America was the largest region in the dermatology OTC medications market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermatology otc medications market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dermatology otc medications market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dermatology OTC medication market consists of sales of roasted moisturizers, shampoo, and acne products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dermatology OTC Medications Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dermatology otc medications market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dermatology otc medications ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dermatology otc medications market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Tablets And Capsules; Oils Gels; Creams And Ointments; Other Types
• 2) By Indication: Dermatitis; Acne; Psoriasis; Skin Bleaching; Anti-Fungal; Wart Remover; Other Indications
• 3) By Route Of Administration: Topical; Oral
• 4) By Distribution Channel: Online Distribution; Offline Distribution
• Subsegments:
• 1) By Tablets And Capsules: Oral Antihistamines; Anti-Inflammatory Tablets; Nutritional Supplements
• 2) By Oils Gels: Herbal Oils; Medicated Gels; Moisturizing Oils
• 3) By Creams And Ointments: Corticosteroid Creams; Antifungal Creams; Moisturizers And Emollients
• 4) By Other Types: Lotions; Sprays; Foams
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dermatology OTC Medications Market Characteristics

3. Dermatology OTC Medications Market Trends And Strategies

4. Dermatology OTC Medications Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Dermatology OTC Medications Growth Analysis And Strategic Analysis Framework

• 5.1. Global Dermatology OTC Medications PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Dermatology OTC Medications Market Growth Rate Analysis
• 5.4. Global Dermatology OTC Medications Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Dermatology OTC Medications Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Dermatology OTC Medications Total Addressable Market (TAM)

6. Dermatology OTC Medications Market Segmentation

• 6.1. Global Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets And Capsules
• Oils Gels
• Creams And Ointments
• Other Types
• 6.2. Global Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dermatitis
• Acne
• Psoriasis
• Skin Bleaching
• Anti-Fungal
• Wart Remover
• Other Indications
• 6.3. Global Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical
• Oral
• 6.4. Global Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Distribution
• Offline Distribution
• 6.5. Global Dermatology OTC Medications Market, Sub-Segmentation Of Tablets And Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Antihistamines
• Anti-Inflammatory Tablets
• Nutritional Supplements
• 6.6. Global Dermatology OTC Medications Market, Sub-Segmentation Of Oils Gels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Herbal Oils
• Medicated Gels
• Moisturizing Oils
• 6.7. Global Dermatology OTC Medications Market, Sub-Segmentation Of Creams And Ointments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroid Creams
• Antifungal Creams
• Moisturizers And Emollients
• 6.8. Global Dermatology OTC Medications Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lotions
• Sprays
• Foams

7. Dermatology OTC Medications Market Regional And Country Analysis

• 7.1. Global Dermatology OTC Medications Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Dermatology OTC Medications Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dermatology OTC Medications Market

• 8.1. Asia-Pacific Dermatology OTC Medications Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dermatology OTC Medications Market

• 9.1. China Dermatology OTC Medications Market Overview
• 9.2. China Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dermatology OTC Medications Market

• 10.1. India Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dermatology OTC Medications Market

• 11.1. Japan Dermatology OTC Medications Market Overview
• 11.2. Japan Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dermatology OTC Medications Market

• 12.1. Australia Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dermatology OTC Medications Market

• 13.1. Indonesia Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dermatology OTC Medications Market

• 14.1. South Korea Dermatology OTC Medications Market Overview
• 14.2. South Korea Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dermatology OTC Medications Market

• 15.1. Western Europe Dermatology OTC Medications Market Overview
• 15.2. Western Europe Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dermatology OTC Medications Market

• 16.1. UK Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dermatology OTC Medications Market

• 17.1. Germany Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dermatology OTC Medications Market

• 18.1. France Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dermatology OTC Medications Market

• 19.1. Italy Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dermatology OTC Medications Market

• 20.1. Spain Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dermatology OTC Medications Market

• 21.1. Eastern Europe Dermatology OTC Medications Market Overview
• 21.2. Eastern Europe Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dermatology OTC Medications Market

• 22.1. Russia Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dermatology OTC Medications Market

• 23.1. North America Dermatology OTC Medications Market Overview
• 23.2. North America Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dermatology OTC Medications Market

• 24.1. USA Dermatology OTC Medications Market Overview
• 24.2. USA Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dermatology OTC Medications Market

• 25.1. Canada Dermatology OTC Medications Market Overview
• 25.2. Canada Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dermatology OTC Medications Market

• 26.1. South America Dermatology OTC Medications Market Overview
• 26.2. South America Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dermatology OTC Medications Market

• 27.1. Brazil Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dermatology OTC Medications Market

• 28.1. Middle East Dermatology OTC Medications Market Overview
• 28.2. Middle East Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dermatology OTC Medications Market

• 29.1. Africa Dermatology OTC Medications Market Overview
• 29.2. Africa Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dermatology OTC Medications Market Competitive Landscape And Company Profiles

• 30.1. Dermatology OTC Medications Market Competitive Landscape
• 30.2. Dermatology OTC Medications Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Dermatology OTC Medications Market Other Major And Innovative Companies

• 31.1. Bristol Myers Squibb Co
• 31.2. GlaxoSmithKline Plc
• 31.3. Acella Pharmaceuticals LLC
• 31.4. Eli Lilly and Company
• 31.5. Amgen Inc.
• 31.6. Allergan plc
• 31.7. Viatris Inc.
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Mylan N.V.
• 31.10. Astellas Pharma Inc.
• 31.11. Bausch Health Companies Inc.
• 31.12. Sun Pharmaceutical Industries Inc.
• 31.13. Perrigo Company PLC
• 31.14. Galderma S.A.
• 31.15. Dr. Reddy's Laboratories Ltd.

32. Global Dermatology OTC Medications Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dermatology OTC Medications Market

34. Recent Developments In The Dermatology OTC Medications Market

35. Dermatology OTC Medications Market High Potential Countries, Segments and Strategies

• 35.1 Dermatology OTC Medications Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Dermatology OTC Medications Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Dermatology OTC Medications Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer